Nantahala Capital Management, LLC Rezolute, Inc. Put Options Transaction History
Nantahala Capital Management, LLC
- $1.99 Billion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding RZLT
# of Institutions
70Shares Held
43.8MCall Options Held
187KPut Options Held
24.6K-
Federated Hermes, Inc. Pittsburgh, PA11.3MShares$55.5 Million0.13% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.8MShares$13.8 Million2.6% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA2.53MShares$12.4 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.32MShares$11.4 Million0.0% of portfolio
-
Blackstone Inc New York, NY1.74MShares$8.58 Million0.04% of portfolio
About Rezolute, Inc.
- Ticker RZLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,827,600
- Market Cap $191M
- Description
- Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultr...